About SOMAÍ
compassionate care scientifically crafted
At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine.
SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of a few and the first European-based vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.
Our Product Categories
For patients
FOR HEALTHCARE PROFESSIONALs
For partners
Company News
SOMAÍ Partners with SHERBINSKIS and BOUTIQ
A New Era for Medical Cannabis: SOMAÍ Teams Up with Iconic California Brands SHERBINSKIS and BOUTIQ for Europe and Australia…
Read more
Ireland Could Make Great Cannabis Policy: Examining the Past to Look Forward
Access to safe and controlled cannabis for the Irish people is being decided upon in 2025. Watching a country make…
Read more
Product Dumping, White Labels, and Conflicts of Interest Lead to Global Cannabis Price Catastrophe
2025 has kicked off fast and furious for the global cannabis industry as volumes increase and more countries come online…
Read more
The Rise of Multi-Country Operators: Somai Targets 20 Countries by Year End
Multi-state operators, or MSO’s, have long represented the biggest and most influential cannabis players in North America. Yet, as that…
Read more
SOMAÍ Pharmaceuticals Redefines Patients Experience with the Launch of Origins and Senses Lines
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company, proudly announces the global launch of its Origins and…
Read more
Portugal em Direto – Maior Empresa Da Europa Está Em Portugal
Portugal é o “epicentro do cultivo e produção de canábis”, revela CEO da SOMAÍ Pharmaceuticals
Com uma das maiores infraestruturas para cultivo e produção de canábis, Portugal é o maior exportador europeu desta planta para…
Read more
SOMAÍ Pharmaceuticals e Universidade Lusófona colaboram em publicação científica sobre o efeito ‘entourage’
A indústria da canábis medicinal continua a evoluir, com a investigação a abrir caminho para aplicações terapêuticas inovadoras. A SOMAÍ Pharmaceuticals,…
Read more
Michael Sassano: “Portugal is the epicentre of cannabis cultivation and production. This is a place that will thrive”
Michael Sassano’s main goal at SOMAÍ is to produce the most advanced products with the most innovative administration routes, to…
Read more
Impairment Vs Presence Of Cannabis: The International Cannabis Driving Debate Continues
Around the world, the debate continues about how to quantify the presence of cannabis in an individual’s system and how…
Read more
Give and Toke: Excitement in Global Markets w/ Michael Sassano (SOMAÍ Pharmaceuticals)
Listen to the latest episode of the Give and Toke podcast, which elevates the conversation about cannabis to a higher…
Read more
Drug Science: What is the UK medical cannabis industry looking like in 2024?
We are 6 years on from legalisation of cannabis-based medical products in the UK and although many patients have now…
Read more
EU Medical Cannabis Meets Recreational Choice: A New Era in European Preference
Europe has been one of the most interesting cannabis markets to watch develop: What was a pure medical cannabis market has…
Read more
SOMAÍ Pharmaceuticals Announces Partnership with Releaf Clinic to Bring Innovative Cannabis Solutions to UK Patients
This collaboration marks the synergy of two vertically integrated fast-growing companies. SOMAÍ Pharmaceuticals is proud to announce a strategic partnership…
Read more
Innovations in Cannabis Extracts Entice New Demographics
Interesting trends emerge when we examine the largest extract markets in the global cannabis industry. These trends suggest that innovations…
Read more
SOMAÍ Pharmaceuticals Launches in Ireland, Offering the Broadest Range of Cannabis-Based Medicines to Patients
SOMAÍ Pharmaceuticals (“SOMAÍ”), a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the…
Read more SOMAÍ Pharmaceuticals Launches in Ireland, Offering the Broadest Range of Cannabis-Based Medicines to Patients
SOMAÍ Pharmaceuticals (“SOMAÍ”), a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the…
Read more
What Does the Future Hold for UK Cannabis?
After a recent conversation with Pierre van Weperen of Grow Group PLC and Grow Pharma, his vision of the United Kingdom’s…
Read more